Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

Karl S. Lang; Mike Recher; Tobias Junt; Alexander A. Navarini; Nicola L. Harris; Stefan Freigang; Bernhard Odermatt; Curdin Conrad; Lars M. Ittner; Stefan Bauer; Sanjiv A. Luther; Satoshi Uematsu; Shizuo Akira; Hans Hengartner; Rolf M. Zinkernagel

doi:10.1038/nm1176

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

Karl S. Lang^*, Mike Recher, Tobias Junt, Alexander A. Navarini, Nicola L. Harris, Stefan Freigang, Bernhard Odermatt, Curdin Conrad, Lars M. Ittner, Stefan Bauer, Sanjiv A. Luther, Satoshi Uematsu, Shizuo Akira, Hans Hengartner, Rolf M. Zinkernagel

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

343 Citations (Scopus)

Abstract

Autoimmune diabetes mellitus in humans is characterized by immunological destruction of pancreatic beta islet cells. We investigated the circumstances under which CD8⁺ T cells specific for pancreatic beta-islet antigens induce disease in mice expressing lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) as a transgene under the control of the rat insulin promoter. In contrast to infection with LCMV, immunization with LCMV-GP derived peptide did not induce autoimmune diabetes despite large numbers of autoreactive cytotoxic T cells. Only subsequent treatment with Toll-like receptor ligands elicited overt autoimmune disease. This difference was critically regulated by the peripheral target organ itself, which upregulated class I major histocompatibility complex (MHC) in response to systemic Toll-like receptor-triggered interferon-α production. These data identify the 'inflammatory status' of the target organ as a separate and limiting factor determining the development of autoimmune disease.

Original language	English
Pages (from-to)	138-145
Number of pages	8
Journal	Nature Medicine
Volume	11
Issue number	2
DOIs	https://doi.org/10.1038/nm1176
Publication status	Published - 1 Feb 2005
Externally published	Yes

Bibliographical note

A corrigendum exists for this article, and can be found in Nature Medicine (2005) Vol 11, 1256. at https://doi.org/10.1038/nm1105-1256

Access to Document

10.1038/nm1176

Cite this

Lang, K. S., Recher, M., Junt, T., Navarini, A. A., Harris, N. L., Freigang, S., Odermatt, B., Conrad, C., Ittner, L. M., Bauer, S., Luther, S. A., Uematsu, S., Akira, S., Hengartner, H., & Zinkernagel, R. M. (2005). Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nature Medicine, 11(2), 138-145. https://doi.org/10.1038/nm1176

@article{22f7fb427665461288ca1720ba6ef379,

title = "Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease",

abstract = "Autoimmune diabetes mellitus in humans is characterized by immunological destruction of pancreatic beta islet cells. We investigated the circumstances under which CD8+ T cells specific for pancreatic beta-islet antigens induce disease in mice expressing lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) as a transgene under the control of the rat insulin promoter. In contrast to infection with LCMV, immunization with LCMV-GP derived peptide did not induce autoimmune diabetes despite large numbers of autoreactive cytotoxic T cells. Only subsequent treatment with Toll-like receptor ligands elicited overt autoimmune disease. This difference was critically regulated by the peripheral target organ itself, which upregulated class I major histocompatibility complex (MHC) in response to systemic Toll-like receptor-triggered interferon-α production. These data identify the 'inflammatory status' of the target organ as a separate and limiting factor determining the development of autoimmune disease.",

author = "Lang, \{Karl S.\} and Mike Recher and Tobias Junt and Navarini, \{Alexander A.\} and Harris, \{Nicola L.\} and Stefan Freigang and Bernhard Odermatt and Curdin Conrad and Ittner, \{Lars M.\} and Stefan Bauer and Luther, \{Sanjiv A.\} and Satoshi Uematsu and Shizuo Akira and Hans Hengartner and Zinkernagel, \{Rolf M.\}",

note = "A corrigendum exists for this article, and can be found in Nature Medicine (2005) Vol 11, 1256. at https://doi.org/10.1038/nm1105-1256",

year = "2005",

month = feb,

day = "1",

doi = "10.1038/nm1176",

language = "English",

volume = "11",

pages = "138--145",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Springer, Springer Nature",

number = "2",

}

TY - JOUR

T1 - Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

AU - Lang, Karl S.

AU - Recher, Mike

AU - Junt, Tobias

AU - Navarini, Alexander A.

AU - Harris, Nicola L.

AU - Freigang, Stefan

AU - Odermatt, Bernhard

AU - Conrad, Curdin

AU - Ittner, Lars M.

AU - Bauer, Stefan

AU - Luther, Sanjiv A.

AU - Uematsu, Satoshi

AU - Akira, Shizuo

AU - Hengartner, Hans

AU - Zinkernagel, Rolf M.

N1 - A corrigendum exists for this article, and can be found in Nature Medicine (2005) Vol 11, 1256. at https://doi.org/10.1038/nm1105-1256

PY - 2005/2/1

Y1 - 2005/2/1

N2 - Autoimmune diabetes mellitus in humans is characterized by immunological destruction of pancreatic beta islet cells. We investigated the circumstances under which CD8+ T cells specific for pancreatic beta-islet antigens induce disease in mice expressing lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) as a transgene under the control of the rat insulin promoter. In contrast to infection with LCMV, immunization with LCMV-GP derived peptide did not induce autoimmune diabetes despite large numbers of autoreactive cytotoxic T cells. Only subsequent treatment with Toll-like receptor ligands elicited overt autoimmune disease. This difference was critically regulated by the peripheral target organ itself, which upregulated class I major histocompatibility complex (MHC) in response to systemic Toll-like receptor-triggered interferon-α production. These data identify the 'inflammatory status' of the target organ as a separate and limiting factor determining the development of autoimmune disease.

AB - Autoimmune diabetes mellitus in humans is characterized by immunological destruction of pancreatic beta islet cells. We investigated the circumstances under which CD8+ T cells specific for pancreatic beta-islet antigens induce disease in mice expressing lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) as a transgene under the control of the rat insulin promoter. In contrast to infection with LCMV, immunization with LCMV-GP derived peptide did not induce autoimmune diabetes despite large numbers of autoreactive cytotoxic T cells. Only subsequent treatment with Toll-like receptor ligands elicited overt autoimmune disease. This difference was critically regulated by the peripheral target organ itself, which upregulated class I major histocompatibility complex (MHC) in response to systemic Toll-like receptor-triggered interferon-α production. These data identify the 'inflammatory status' of the target organ as a separate and limiting factor determining the development of autoimmune disease.

UR - https://www.scopus.com/pages/publications/20044385554

UR - http://www.scopus.com/inward/record.url?scp=30744440891&partnerID=8YFLogxK

UR - https://doi.org/10.1038/nm1105-1256

U2 - 10.1038/nm1176

DO - 10.1038/nm1176

M3 - Article

C2 - 15654326

AN - SCOPUS:20044385554

SN - 1078-8956

VL - 11

SP - 138

EP - 145

JO - Nature Medicine

JF - Nature Medicine

IS - 2

ER -

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this